David Harlan to Thrombocythemia, Essential
This is a "connection" page, showing publications David Harlan has written about Thrombocythemia, Essential.
Connection Strength
0.015
-
Ferrant JL, Benjamin CD, Cutler AH, Kalled SL, Hsu YM, Garber EA, Hess DM, Shapiro RI, Kenyon NS, Harlan DM, Kirk AD, Burkly LC, Taylor FR. The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge. Int Immunol. 2004 Nov; 16(11):1583-94.
Score: 0.015